en · de · es · fr · pt
analytical-notes.peptides6608.com › News › Identity And Pharmacological Classification — Field Notes

Identity And Pharmacological Classification — Field Notes

By Editorial Desk · published 2025-11-19 · last reviewed 2025-12-21 · News

A practical reference on research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2025-12-21. Anything still debated is marked as such rather than presented as settled.

Identity and Pharmacological Classification

PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.

Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.

Mechanism and Research Context

In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.

GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.

Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.

Cardarine at a glance

PropertyValueNotes
Chemical classPPARδ agonistNot an anabolic steroid.
Common synonymsGW501516, GW-1516Cardarine is an informal name.
AppearanceWhite to off-white powderTypical for research-grade solid.
Solubility classPoorly soluble in water; soluble in some organic solventsSuch as DMSO or ethanol in laboratory settings.
Typical storage temperatureCool, dry, protected from lightSpecific conditions vary by supplier and form.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Related pages on this site

Preclinical Findings and Safety Signals

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Background from the literature

By 2015, the average fiber content per pack of MRE has improved to an adequate 12 grams. A superstition exists among troops about the Charms candies that come with some menus: they are considered bad luck, especially if actually eaten. In March 2007, The Salt Lake Tribune invited three gourmet chefs to taste-test 18 MRE meals. None of the meals rated higher than a 5.7 average on a scale of 1 to 10, and the chicken fajita meal in particular was singled out for disdain, rating an average score of 1.3. In 2010, the New York Times reported that a French combat ration (such as cassoulet with accompaniments of deer pâté and nougat) could be traded for around five MREs, though by 2014 it was claimed that MRE menus had improved to the point that their worth had reversed. The vegetable cheese omelet MRE, Recipe No. 4, introduced in 2005, is generally considered the worst ever. Soldiers serving in Iraq dubbed it the "Vomelet" (a pun with vomit), both for its appearance and taste. It was discontinued in 2009.

=== Efficacy === There is an average 52% decrease in inflammatory acne lesions by week 12. The combination is less effective than benzoyl peroxide/salicylic acid after short-term treatment of two to four weeks, but the two treatments showed similar effectiveness after ten to twelve weeks.

=== Scotland to England in 2007 === On 29 April 2007, he began walking again at John o' Groats and arrived at Land's End on 8 June, having covered 900 miles (1,400 km) in 6 weeks. On the walk in Britain he visited 20 hospices and raised £10,000 for hospice through sales of his Beyond the Setting Sun book.

This was an extremely exciting time for us since we had funding from five pharmaceutical companies to actually produce a commercial product that would be used by their computational chemists and their synthetic chemists who might be interested in doing modeling as well. So, the software had to be accessible to the novice and expert alike and had to actually do something useful! Clark worked alongside the rest of us, and we all worked very hard to ensure that the molecular mechanics calculations churned out by our code were reasonably accurate and that the user interface was as intuitive as possible. One particularly notable feature of MacroModel was the inclusion of an implicit solvation model known as GB/SA (generalized Born model augmented with the hydrophobic solvent accessible surface area term). The GB/SA model simulated solvent interactions with organic molecules by incorporating a continuous solvent field instead of including explicit individual solvent molecules in the computation. Still disclosed a full description of MacroModel in the Journal of Computation Chemistry in 1990, and the rights to this software were later acquired by Schrodinger, Inc. in 1998.

Chair of Trustees, Molly Rose Foundation. For services to Child Safety Online. Martin Henry Charles Russell, DL. For services to the community in the London Borough of Barnet. Rosemary Priscilla Irene Russell. Art and Design and Technology Technician, The Ursuline Academy Ilford. For services to Education and to Diversity in STEM. Elizabeth Joan Ryan. Lately Volunteer, Luton, South Bedfordshire and Harpenden Samaritans. For services to Suicide Prevention. Sadia Sadiq. Manager, Community Care and Wellbeing Services. For services to Minority Ethnic Communities in Wales. Lorraine Sanda. Strategic Director of People, Clackmannanshire Council. For services to Children and Families. Carolene Euleata Sargeant (Carolene Hinds). Independent Performing Arts Professional. For services to Dance. Professor William Peter Saunders. Chief Creative Officer, StoryFutures at Royal Holloway University. For services to the Creative Industries. Alison Melanie Savage. Officer Commanding, The Services Cotswold Centre. For services to Military Families. Jacqueline Savage. Volunteer. For services to Social Care. Majida Aly Sayam. Founder and Director, Jannaty Women's Social Society. For charitable services to Ethnic Minority Women. Kimberley Louise Scott. Lately Assistant Director of Education, Education Authority. For services to Education. Jacqueline Scrivens (Jacqueline Forester). Proprietor, The Woodshed Forest School Nursery. For services to Early Years Child-Lead Learning. Josephine Patricia Segal. Co-Founder, Spread a Smile.

Sources: en.wikipedia.org

Reference notes

Tumor growth (see HP59) Revascularization or neovascularization after trauma, for example, after cardiac ischemia or retinal ischemia Endometriosis - It appears that up to 37% of the microvascular endothelium of the ectopic endometrial tissue originates from endothelial progenitor cells.

== Career == Henriksen found work as a muralist and as a laborer on ships. For a time, he worked in Europe. Around age 30, he found theater work as a set designer, and he received his first acting role because he built the set for a production. It was around this time that he taught himself to read. For his first role, he put the entire script on tape with the help of a friend, then learned his part and all of the others. Soon afterward, he graduated from the Actors Studio and began acting in New York City. Henriksen's first film appearance was in The Outsider in 1961, as an uncredited extra. He received his first credit in his second film, 1972's It Ain't Easy. He auditioned for the role of Leon Shermer in Dog Day Afternoon (1975), but received the smaller part of an FBI agent that kills John Cazale's character. He appeared in two more films directed by Sidney Lumet: Network (1976) and Prince of the City (1981). In a 2009 interview, Henriksen called Lumet "the kind of guy that loves New York actors, because that's where he works and that's what he knows....He would give you the job that was maybe only meant for four days, and he'd give you the run of the show because he wanted to help support young actors in New York." Henriksen had supporting roles in a variety of films, including the science-fiction film Close Encounters of the Third Kind (1977) and the horror film Damien - Omen II (1978). He also had co-starring roles in the low-budget horror film Mansion of the Doomed (1976) and the Italian-produced science fiction film The Visitor (1979).

Source: INCB Red List (14th Edition, January 2015) The list of 23 substances is identical to list of EU-controlled drug precursors, except for the different categorization and inclusion of stereoisomers in EU Category 1.

Most people with back pain do not experience chronic severe pain but rather persistent or intermittent pain that is mild or moderate. Still, chronic back pain symptoms, defined as repeated or persistent pain for at least 3 months within the past 12 months, affected 34.4% of a nationwide sample of adults in mild form, 25.1% in moderate form, and 13% in (very) severe form. In most cases of herniated disks and stenosis, rest, injections or surgery have similar general pain-resolution outcomes on average after one year. In the United States, acute low back pain is the fifth most common reason for physician visits and causes 40% of missed work days. It is the single leading cause of disability worldwide. According to the World Health Organization, approximately 90% of all low back pain cases are non-specific, meaning that no clear structural cause can be identified.

Sources: en.wikipedia.org

Reference notes

=== Pregnancy and breastfeeding === Research on animal reproduction has indicated that there is a trace of teratogenicity when doses are reduced by 10 times the human recommended dose. There is no sufficient information on human pregnancy at this moment. Use is only recommended when the potential benefits outweigh the potential risks for the pregnant mother and the fetus. Prednisolone when delivered systemically can be found in the mother's breast milk, however, there is no data provided for the extent of prednisolone found in the system after administering eye drops. However, the presence of corticosteroids is recorded when they are administered systemically, and it could affect the fetus' growth. Therefore, the use of prednisolone during breastfeeding is not advocated.

21 February – The Government agreed a more targeted cost-of-living package, along with some universal payments, with €470m to be allocated for social protection measures. 22 February – Róisín Shortall and Catherine Murphy announced that they would stand down as co-leaders of the Social Democrats, with a successor to be appointed "at an early date." On 26 February, Holly Cairns was announced as the next leader of the party. 28 February – Minister for Education Norma Foley reversed a plan for Leaving Certificate candidates to sit Paper 1 of their English and Irish exams at the end of fifth year, after facing strong opposition from a number of organisations, including teacher and student representative bodies.

=== Ligand exchange/functionalization === After initial nanoparticle synthesis, colloidal gold ligands are often exchanged with new ligands designed for specific applications. For example, Au NPs produced via the Turkevich-style (or Citrate Reduction) method are readily reacted via ligand exchange reactions, due to the relatively weak binding between the carboxyl groups and the surfaces of the NPs. This ligand exchange can produce conjugation with a number of biomolecules from DNA to RNA to proteins to polymers (such as PEG) to increase biocompatibility and functionality. For example, ligands have been shown to enhance catalytic activity by mediating interactions between adsorbates and the active gold surfaces for specific oxygenation reactions. Ligand exchange can also be used to promote phase transfer of the colloidal particles. Ligand exchange is also possible with alkane thiol-arrested NPs produced from the Brust-type synthesis method, although higher temperatures are needed to promote the rate of the ligand detachment. An alternative method for further functionalization is achieved through the conjugation of the ligands with other molecules, though this method can cause the colloidal stability of the Au NPs to breakdown.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine also known as?

Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.

Is cardarine a steroid?

No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.

Has cardarine been approved for human use?

No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.

How does cardarine work in the body?

It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.

Network